ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 30 Mar 2009
Last Applicant/ Owned by
345 Park Avenue
New York
NY
10154
Serial Number
78534207 filed on 17th Dec 2004
Registration Number
N/A
Correspondent Address
Nadine P. Flynn
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
STAXMEDOR
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents
Mark Details
Serial Number
No 78534207
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th Mar 2009 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 30th Mar 2009 | ABANDONMENT - NO USE STATEMENT FILED |
| 25th Jul 2008 | EXTENSION 5 GRANTED |
| 25th Jul 2008 | TEAS EXTENSION RECEIVED |
| 25th Jul 2008 | EXTENSION 5 FILED |
| 13th Dec 2007 | EXTENSION 4 GRANTED |
| 13th Dec 2007 | EXTENSION 4 FILED |
| 13th Dec 2007 | TEAS EXTENSION RECEIVED |
| 23rd Jul 2007 | EXTENSION 3 FILED |
| 23rd Jul 2007 | EXTENSION 3 GRANTED |